Implementation of daily patient-reported outcome measurements to support children with cancer

Andreas Meryk1, Gabriele Kropshofer1, Benjamin Hetzer1

  • 1Department of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria.

Pediatric Blood & Cancer
|August 12, 2021
PubMed

Insights

Daily symptom monitoring using patient-reported outcome measures (PROMs) is feasible for children with cancer. This approach enables early symptom detection and timely clinical interventions, improving patient-directed cancer care.

Area of Science:

  • Pediatric Oncology
  • Digital Health
  • Patient-Reported Outcomes

Background:

  • Patient-directed cancer care emphasizes the importance of symptom self-reporting.
  • Current clinical services lack robust systems for daily symptom monitoring and integration into care.
  • There is a need to evaluate daily patient-reported outcome measures (PROMs) in pediatric oncology.

Purpose of the Study:

  • To assess the feasibility and value of daily PROMs in children undergoing chemotherapy.
  • To evaluate the usability and satisfaction with a web-based daily reporting system.

Main Methods:

  • A web-based, child-friendly patient portal (ePROtect) was used for daily health status recording.
  • Feasibility was assessed through completion rates and time.
  • Usability, satisfaction, and clinical interventions triggered by symptom changes were evaluated.

Main Results:

  • Twelve children (median age 7.2 years) participated, generating 891 daily reports.
  • High completion rates were observed (median 85.3% inpatient, 55.9% outpatient).
  • Mean completion time was 47.6 seconds; severe symptoms prompted interventions in 57 cases, with high patient/proxy satisfaction (>90%) and usefulness (>80%) reported.

Conclusions:

  • Daily symptom monitoring via PROMs is feasible for children aged 5-18 with newly diagnosed cancer.
  • This monitoring facilitates early identification of symptoms and timely clinical action.
  • The ePROtect system demonstrates value in enhancing patient-directed cancer care.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.3K
Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.1K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
37
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K